Accordingly, MET gene amplification predicted higher MPZL3 expression than cell lines without any RTK amplification and MPZL3 levels are positively correlated with MET and ERBB3 expression in LUSC and gastric carcinomas. The gene discussed is ERBB3; the disease is gastric carcinoma.